Navigation Links
Landauer, Inc. Announces Executive Management Change

GLENWOOD, Ill., Aug. 22, 2014 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, announced today that William E. Saxelby, its President and Chief Executive Officer, will be stepping down as President and Chief Executive Officer and as a member of the Board of Directors, effective as of September 15, 2014.  He will be replaced on an interim basis by Michael T. Leatherman, a member of the Company's Board of Directors since 2008.  The Board has commenced a search, which will consider internal and external candidates, for a permanent successor to Mr. Saxelby.  Mr. Saxelby has agreed to work with Mr. Leatherman in the near term in an advisory role.

"No one has worked harder than Bill to enhance the Landauer brand, expand Landauer's service offerings and extend the Company's reach into new markets.  We thank Bill for his dedicated leadership of Landauer over the past nine years and wish him well in all of his future endeavors," said Chairman of the Company's Board of Directors Robert J. Cronin

About Landauer
Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure, the leading domestic provider of outsourced medical physics services, as well as a provider of high quality medical accessories used in radiology, radiation therapy, and image guided surgery procedures.  For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees.  Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings.  The Company provides its dosimetry services to approximately 1.8 million individuals globally.  In addition, through its Medical Physics segment, the Company provides therapeutic and imaging physics services to the medical physics community. Through its Medical Products segment, the Company provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures.  For information about Landauer, please visit their website at

For the latest news releases and other corporate documents on Landauer, Inc., visit

SOURCE Landauer, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results
2. Landauer, Inc. Reports Fiscal 2013 Fourth Quarter And Year End Results
3. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2013 Results
4. Landauer, Inc. Reports Fiscal 2013 Third Quarter Results
5. Landauer, Inc. Declares Regular Cash Dividend
6. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
7. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Second Quarter 2013 Results
8. Landauer, Inc. Reports Fiscal 2013 First Quarter Results
9. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
10. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
11. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
Post Your Comments:
(Date:11/24/2015)... 25, 2015 WuXi PharmaTech (Cayman) Inc. ("WuXi" ... open-access R&D capability and technology platform company serving the ... China and the ... extraordinary general meeting of shareholders held today, the Company,s ... and approve the previously announced agreement and plan of ...
(Date:11/24/2015)... N.C. , Nov. 24, 2015  In the ... projects in an effort to quickly uncover new insights, ... --> --> However, ... a market research project and ensure that all rules ... and industry standards. Another major barrier to efficiently launching ...
(Date:11/24/2015)... Va. , Nov. 24, 2015  DILON Diagnostics ... have signed an agreement for DILON to distribute GE,s ... across the globe. The signing of this distribution agreement will ... NM750b Molecular Breast Imaging system and is considered an ... provide better healthcare solutions for clinicians and their patients. ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also known ... people who find their cholesterol levels and weight are creeping up are more likely ... don’t have any of the other symptoms. , Thyroid hormone plays a major role ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis ... Care Plan software creates an agreement between the practice owner and the patient ... scheduling, monitoring, notification, and projections. Click here to learn more. ...
(Date:11/24/2015)... ... , ... Charitable giving is at its peak during the holidays. In ... of the year totalling over $358 billion in 2014. With more than 1.5 ... those individuals who want to “give back” during the holidays. , “With so many ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... national leaders when it comes to several aspects of orthopedic care. They have ... replacements, orthopedic surgeries and general orthopedic care. , Becker's Hospital Review selected ...
(Date:11/24/2015)... Port Richey, FL (PRWEB) , ... November 24, 2015 , ... ... it deems a growing epidemic as deaths from prescription opioids in the United States ... heroin and cocaine. In 2013 alone, opioids were involved in 37 percent of all ...
Breaking Medicine News(10 mins):